Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the National Prostate Cancer Audit's report entitled NPCA State of the Nation Report 2024, published in January 2025, if he will take steps to tackle inequalities in accessing NICE-recommended treatments following advanced prostate cancer diagnosis for (a) black men and (b) men from areas of socio-economic deprivation.

Making improvements across different cancer types, including prostate cancer, is critical to reducing disparities in cancer survival. Early cancer diagnosis is also a specific priority within the National Health Service’s wider Core20Plus5 approach to reducing healthcare inequalities.

To address disparities and find ways to better detect prostate cancer earlier, we have invested £16 million in the United Kingdom-wide TRANSFORM trial, aimed at helping find the best ways of detecting prostate cancer in men, even if they are not displaying any symptoms. This research will aim to address some of the inequalities that exist in prostate cancer diagnosis by targeting black men in trial recruitment, ensuring that one in ten participants are black men.

We have also asked the National Screening Committee to review the evidence for prostate cancer screening, including for high-risk groups like black men.

As part of our wider strategy on early diagnosis, we are directly targeting our activity at areas we know will make a difference. This includes awareness raising campaigns such as the NHS Help Us, Help You campaign, to increase awareness of cancer symptoms and encourage people to get checked.

The NHS England Cancer Programme also commissions clinical cancer audits, which provide timely evidence for cancer service providers of where patterns of care in England may vary, increase the consistency of access to treatments, and help stimulate improvements in cancer treatment and outcomes for patients, including those with prostate cancer.

Following publication of the 10-Year Health Plan, we will publish a new National Cancer Plan, which will include further details on how we will improve access to treatments and outcomes for all tumour types, including prostate cancer. We are now in discussions about what form that plan should take, and what its relationship to the 10-Year Health Plan and the Government’s wider Health Mission should be. We will provide updates on this in due course.

We need to tackle the inequalities that people from different groups face, which will be part of the National Cancer Plan as we look at addressing all barriers to providing cancer care across prevention, diagnosis, screening and treatment.